Hepatitis C drugs on SilverScript Choice (S5601-002)
Epclusa, Mavyret, Harvoni and their generics, checked against this plan's 2026 formulary (its list of covered drugs).
- Plan type
- Stand-alone drug plan (PDP), Maine + 1 more
- Premium
- $94.90/month
- Deductible
- $615.00
3 of 6 Hepatitis C drugs are covered on this plan. All 3 require prior authorization.
3 aren't on the formulary, including sofosbuvir-velpatasvir and Harvoni.
- 25%Tier 5
- 25%Tier 5
- $6,568.20Tier 5
Not on the formulary
sofosbuvir-velpatasvir, Harvoni, ledipasvir-sofosbuvir
Patient cost for a 30-day supply at a preferred retail pharmacy, after the $615.00 deductible where it applies. Where the plan charges a percentage (coinsurance), the dollar figure is that share of the plan's negotiated price; "from" means other strengths cost more. Data from the CMS 2026 Part D formulary and pricing files.